GLASF
Price
$4.35
Change
+$0.02 (+0.46%)
Updated
Apr 11 closing price
Capitalization
203.76M
ORXOY
Price
$1.48
Change
-$0.37 (-20.00%)
Updated
Feb 13 closing price
Capitalization
57.75M
Ad is loading...

GLASF vs ORXOY

Header iconGLASF vs ORXOY Comparison
Open Charts GLASF vs ORXOYBanner chart's image
Glass House Brands
Price$4.35
Change+$0.02 (+0.46%)
Volume$105.39K
Capitalization203.76M
Orexo AB
Price$1.48
Change-$0.37 (-20.00%)
Volume$925
Capitalization57.75M
GLASF vs ORXOY Comparison Chart
Loading...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLASF vs. ORXOY commentary
Apr 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and ORXOY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 13, 2025
Stock price -- (GLASF: $4.35 vs. ORXOY: $1.48)
Brand notoriety: GLASF and ORXOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GLASF: 71% vs. ORXOY: 100%
Market capitalization -- GLASF: $203.76M vs. ORXOY: $57.75M
GLASF [@Pharmaceuticals: Other] is valued at $203.76M. ORXOY’s [@Pharmaceuticals: Other] market capitalization is $57.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileORXOY’s FA Score has 0 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • ORXOY’s FA Score: 0 green, 5 red.
According to our system of comparison, ORXOY is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 4 TA indicator(s) are bullish.

  • GLASF’s TA Score: 4 bullish, 5 bearish.

Price Growth

GLASF (@Pharmaceuticals: Other) experienced а +4.07% price change this week, while ORXOY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.37%. For the same industry, the average monthly price growth was -3.00%, and the average quarterly price growth was -12.91%.

Industries' Descriptions

@Pharmaceuticals: Other (-0.37% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLASF($204M) has a higher market cap than ORXOY($57.7M). ORXOY YTD gains are higher at: -21.751 vs. GLASF (-25.000). GLASF has higher annual earnings (EBITDA): -24.02M vs. ORXOY (-79.4M). ORXOY has more cash in the bank: 251M vs. GLASF (13.4M). GLASF has less debt than ORXOY: GLASF (73.6M) vs ORXOY (517M). ORXOY has higher revenues than GLASF: ORXOY (634M) vs GLASF (106M).
GLASFORXOYGLASF / ORXOY
Capitalization204M57.7M354%
EBITDA-24.02M-79.4M30%
Gain YTD-25.000-21.751115%
P/E RatioN/AN/A-
Revenue106M634M17%
Total Cash13.4M251M5%
Total Debt73.6M517M14%
FUNDAMENTALS RATINGS
ORXOY: Fundamental Ratings
ORXOY
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLASF
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFE21.910.32
+1.48%
Pfizer
ARW97.811.13
+1.17%
Arrow Electronics
GEG1.900.02
+1.06%
Great Elm Group
ASTS23.280.14
+0.61%
AST SpaceMobile
GSHD108.97-2.06
-1.86%
Goosehead Insurance

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
+0.55%
TSNDF - GLASF
63%
Loosely correlated
-10.34%
GTBIF - GLASF
62%
Loosely correlated
+1.41%
TCNNF - GLASF
60%
Loosely correlated
+2.38%
VRNOF - GLASF
58%
Loosely correlated
-1.08%
CURLF - GLASF
57%
Loosely correlated
+5.26%
More

ORXOY and

Correlation & Price change

A.I.dvisor tells us that ORXOY and APNHF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORXOY and APNHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORXOY
1D Price
Change %
ORXOY100%
N/A
APNHF - ORXOY
28%
Poorly correlated
N/A
TKNO - ORXOY
8%
Poorly correlated
+3.33%
SEHCF - ORXOY
5%
Poorly correlated
N/A
GLASF - ORXOY
4%
Poorly correlated
+0.55%
HTSUY - ORXOY
0%
Poorly correlated
N/A
More